IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 445 to 450 of 450

1 January 2007

IDPC Briefing Paper Number 4 - The European Union Drug Strategy: Progress And Problems

This briefing paper gives an overview of the development of drug policies within the European Union, and the institutions and structures that exist to implement and evaluate these policies.

1 January 2007

IDPC 5 Policy Principles

This short paper summarises the five fundamental principles for effective drug policies that have been developed and agreed by IDPC members through research, analysis and debate over the last two years.

1 January 2006

IDPC Briefing Paper Number 1 - The UNGASS Evaluation Process Evaluated

At the 49th Session of the Commission on Narcotic Drugs (CND), held in Vienna in March 2006, a draft resolution was tabled by the European Union (EU) to guide the process of evaluation of the implementation of political declaration and action plans of the 1998 UN General Assembly Special Session (UNGASS) in 2008.

1 January 2006

IDPC Briefing Paper No 2 - The 2006 World Drug Report: winning the war on drugs?

This briefing paper, the second in a series from the IDPC, looks at the issues raised by the publication in June of the latest World Drug Report by the United Nations Office on Drugs and Crime.

1 January 2006

IDPC Briefing Paper Number 3 - Civil Society involvement in the European Union drug strategy

The third briefing paper from IDPC is a response to the call of the European Commission for civil society organisations to express their views on the Commission's Green Paper on the Role of Civil Society in Drugs Policy in the European Union.

1 January 2005

IDPC Position Paper Number 1 - 2005 Commission on Narcotic Drugs

This position paper describes the concerns of some Consortium members at the apparent policy differences emerging between different United Nations agencies, and individual member states, in the run up to the annual meeting of the UN agency responsible for oversight of the global drug control system.